Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To estimate the efficacy of MEGF0444A used in combination with FOLFOX + bevacizumab therapy in patients with previously untreated mCRC, as measured by progression-free survival (PFS)
Inclusion criteria
- PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL CANCER